archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective cd8+ t cell responsesarchaeosome佐剂克服宽容黑色素瘤肿瘤相关抗原诱导保护性的cd8 + t细胞反应.pdfVIP

Hindawi Publishing Corporation Clinical and Developmental Immunology Volume 2010, Article ID 578432, 13 pages doi:10.1155/2010/578432 Research Article Archaeosome Adjuvant Overcomes Tolerance to Tumor-Associated Melanoma Antigens Inducing Protective CD8+ T Cell Responses Lakshmi Krishnan, Lise Deschatelets, Felicity C. Stark, Komal Gurnani, and G. Dennis Sprott National Research Council of Canada, Institute for Biological Sciences, Ottawa, ON, Canada K1A 0R6 Correspondence should be addressed to Lakshmi Krishnan, lakshmi.krishnan@nrc.ca Received 30 July 2010; Revised 15 December 2010; Accepted 23 December 2010 Academic Editor: Y. Yoshikai Copyright © 2010 Lakshmi Krishnan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Vesicles comprised of the ether glycerolipids of the archaeon Methanobrevibacter smithii (archaeosomes) are potent adjuvants for evoking CD8+ T cell responses. We therefore explored the ability of archaeosomes to overcome immunologic tolerance to self- antigens. Priming and boosting of mice with archaeosome-antigen evoked comparable CD8+ T cell response and tumor protection to an alternate boosting strategy utilizing live bacterial vectors for antigen delivery. Vaccination with melanoma antigenic peptides TRP181−189 and Gp10025−33 delivered in archaeosomes resulted in IFN-γ producing antigen-specific CD8+ T cells with strong cytolytic capability and protection against subcutaneous B 16 melanoma. Targeting responses against multiple antigens afforded prolonged median survival against melanoma challenge. Entrapment of multiple peptides within the same vesi